Joep Killestein

T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis

Robert C. Axtell, Brigit A. de Jong, Katia Boniface et al. · Nature Medicine · 2010 · 532 citations · Full text

Life Sciences, Immunology, Neurology +17

Deep gray matter volume loss drives disability worsening in multiple sclerosis

Arman Eshaghi, Ferrán Prados, Wallace Brownlee et al. · Annals of Neurology · 2018 · 439 citations · Full text

Medicine, Neurology, Neuroscience +15

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 337 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +14

Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets

Myron G. Best, Nik Sol, Sjors G. J. G. In ‘t Veld et al. · Cancer Cell · 2017 · 333 citations · Full text

Medicine, Bioinformatics, Molecular Biology +17

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

Jens Kühle, Giulio Disanto, Ruth Dobson et al. · Multiple Sclerosis Journal · 2015 · 296 citations · Full text

Life Sciences, Immunology, Neurology +10